Zymeworks signed a cope with Jazz Prescription drugs to develop and commercialize Zymeworks’ lead drug candidate, zanidatamab, which targets the most cancers marker HER2. Zymeworks will obtain an upfront cost of $50 million and a second cost of $325 million, at Jazz’s possibility, following the discharge of topline knowledge from an ongoing scientific trial. That…
Category Archives: Health/Life Sciences
29
Oct
Oct
Clockwise from top left: A-Alpha Bio CEO David Younger; UW Medicine surgeon Christopher Allan; Apertur CEO Robin Alfieri; Anavasi Diagnostics co-founder Barry Lutz; former PvP Biologics CEO Ingrid Swanson Pultz. (A-Alpha Bio and UW Photos) The University of Washington recently hosted a panel of five entrepreneurs to discuss what it takes to launch a life…
29
Oct
Oct
Fred Hutch psychologist and associate professor Megan Shen at the 2022 GeekWire Summit. (GeekWire Photo / Dan DeLong). The phrase “burnout” has taken on new meaning during the pandemic. Forty percent of people in 2020 said the pandemic had affected their mental health, according to data from the U.S. Centers for Disease Control. Women and…
29
Oct
Oct
Sound Life Sciences co-founders Shyam Gollakota (left) and Jacob Sunshine. (Univ. of Washington and Sound Life Sciences Photos) Google’s got a thing for Seattle health tech startups. The tech giant acquired Sound Life Sciences, a small University of Washington spinout that developed an app to monitor breathing, GeekWire has learned. A Google spokesperson confirmed the…
29
Oct
Oct
Advata CEO Julie Rezek. (Advata Photo) Seattle-area health data analytics provider Advata, recently formed from the merger of six companies, is the latest tech company in Seattle to lay off employees. Advata laid off 32 workers yesterday, according to a statement from the company provided to GeekWire. Advata employed about 150 people in June, when…
29
Oct
Oct
Gabbi CEO and founder Kaitlin Christine. (Gabbi Photo) Gabbi, a Portland, Ore.-based startup building a tool to help women assess their risk for breast cancer, raised $4.4 million. Gabbi’s breast cancer risk calculator is also designed to propose a health action plan. The company aims to launch its product in the beginning of 2023 as…